Invesco Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$65,644,431
-17.4%
2,443,038
+9.6%
0.02%
-14.3%
Q2 2023$79,465,457
+43.5%
2,228,420
+2.2%
0.02%
+40.0%
Q1 2023$55,392,142
-37.5%
2,180,793
-0.2%
0.02%
-42.3%
Q4 2022$88,599,345
+21.0%
2,184,402
-1.4%
0.03%
+8.3%
Q3 2022$73,232,000
-5.5%
2,215,830
+0.7%
0.02%
+4.3%
Q2 2022$77,507,000
-27.8%
2,201,275
-5.7%
0.02%
-14.8%
Q1 2022$107,345,000
-29.8%
2,334,074
+1.2%
0.03%
-27.0%
Q4 2021$152,864,000
+5.8%
2,305,641
-0.3%
0.04%0.0%
Q3 2021$144,429,000
-30.4%
2,313,443
-7.7%
0.04%
-27.5%
Q2 2021$207,590,000
-7.7%
2,506,516
-26.1%
0.05%
-15.0%
Q1 2021$224,851,000
-10.1%
3,390,909
+4.1%
0.06%
-17.8%
Q4 2020$250,053,000
+76.9%
3,258,865
-0.7%
0.07%
+52.1%
Q3 2020$141,377,000
-1.8%
3,283,253
-1.5%
0.05%
-5.9%
Q2 2020$143,917,000
+57.8%
3,332,194
+5.1%
0.05%
+34.2%
Q1 2020$91,204,000
-56.3%
3,170,140
-3.7%
0.04%
-41.5%
Q4 2019$208,707,000
+52.2%
3,290,359
-32.4%
0.06%
+80.6%
Q3 2019$137,114,000
+7.3%
4,865,638
+0.9%
0.04%
+9.1%
Q2 2019$127,747,000
+839.4%
4,820,607
+550.5%
0.03%
+560.0%
Q1 2019$13,599,000
+211.7%
741,084
+110.9%
0.01%
+150.0%
Q4 2018$4,363,000
-80.9%
351,313
-70.6%
0.00%
-71.4%
Q3 2018$22,893,000
+70.9%
1,194,214
+21.2%
0.01%
+75.0%
Q2 2018$13,395,000984,9630.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders